Search the Newsreel

Citizens, Inc. Reports Second Quarter 2026 Financial Results

Citizens, Inc. (NYSE: CIA) reported its financial results for the second quarter ended June 30, 2026, highlighting its fifteenth consecutive quarter of year-over-year direct first-year premium growth and an increase in book value per Class A share for the fourteenth consecutive quarter. The company …

Azenta, Inc. 3Q 2026: Revenue $161.18M, EPS $0.05— 10-Q Summary

Azenta, Inc. reported strong third-quarter 2026 results, with revenue increasing 12% year-over-year to $161.18 million and diluted EPS reaching $0.05, a significant improvement from a loss in the prior year. The company returned to a net income of $2.46 million, driven by growth in …

ZenaTech (Nasdaq: ZENA) grows DaaS footprint and boosts Boardwalktech stake

ZenaTech (Nasdaq: ZENA) is expanding its "Drone as a Service" (DaaS) operations through strategic acquisitions in Ohio and Idaho, extending its U.S. presence to 13 states. The company is also advancing its ZenaDrone technology, including flight testing for the Interceptor P-1 counter-drone system and …

Citizens Financial Group Inc. stock outperforms competitors despite losses on the day

Citizens Financial Group Inc. (CFG) stock declined by 1.59% on Thursday, closing at $72.43. This occurred during a general market downturn where the S&P 500 Index fell by 0.18% and the Dow Jones Industrial Average dropped by 0.85%. Despite the loss, the article title …

Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update

Surrozen, Inc. (Nasdaq: SRZN) announced its financial results for the second quarter ended June 30, 2026, and provided a business update. The company plans to submit an IND application for SZN-8141 for diabetic macular edema (DME) by the end of Q3 2026 and initiate …

Roadzen (NASDAQ:RDZN) Stock Price Up 6.1% - Should You Buy?

Roadzen (NASDAQ:RDZN) shares increased by 6.1% on Monday, trading at $1.22, though volume was below average. The stock remains below its 50-day and 200-day moving averages, and analysts have a cautious "Reduce" consensus rating based on one Hold and one Sell. The company missed …

Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates

Zentalis Pharmaceuticals announced its Q2 2026 financial results, reporting $174.6 million in cash, providing runway into late 2027. The company highlighted progress in its late-stage WEE1 inhibitor, azenosertib, for ovarian cancer, with the DENALI trial's accelerated approval strategy intact following FDA discussions. Topline data …

CFG vs. CBC: Which Stock Is the Better Value Option?

Investors looking for stocks in the Banks - Northeast sector might want to consider either Citizens Financial Group (CFG) or Central Bancompany (CBC). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take …

CITIZENS FINANCIAL SERVICES INC Q2 2026: Net income $10.19M, EPS $4.29(six months) — 10-Q Summary

CITIZENS FINANCIAL SERVICES INC (CZFS) reported strong Q2 2026 results, with net income rising to $10.19M from $8.46M a year prior, and six-month net income reaching $20.56M compared to $16.08M in the previous year. Diluted earnings per share for the six months increased to …

Azenta, Inc. Stock 12‑Month Price Target Raised to $33.8, Implies 12% Upside

Azenta, Inc.'s stock price target has been increased from $27.8 to $33.8 by five analysts, implying a 12% potential upside based on its August 4th closing price. The consensus rating for the stock remains a "Buy" from six analysts. Investors can find more detailed …

ZenaTech completes 27th drone service acquisition in Idaho By Investing.com

ZenaTech, Inc. (NASDAQ:ZENA) has completed its 27th Drone as a Service acquisition by acquiring Benchmark Partners LLC, operating as Galena-Benchmark Engineering, a civil engineering and land surveying firm based in Ketchum, Idaho. This acquisition marks ZenaTech's entry into Idaho, expanding its presence to 13 …

Do Wall Street Analysts Like Citizens Financial Stock?

Finance and money technology asset management background by InfiniteFlow via Adobe Stock Providence, Rhode Island-based Citizens Financial Group, Inc. (CFG) is a bank holding company that provides retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions …

Zenith Minerals (ASX:ZNC) Rises as Patronus Takeover Process Reshapes the Outlook

Citizens, Inc. reports Q2 2026 net loss amid premium growth and rising reserves

Citizens, Inc. reported a net loss of $0.4 million in Q2 2026, a significant drop from $6.5 million net income in Q2 2025, despite its 15th consecutive quarter of year-over-year growth in direct first year premiums. The decline in total revenues to $60.4 million …

Deal or No Deal, AstraZeneca Stock Is a Bargain

AstraZeneca's stock has become a potential bargain after recent investor concerns over a rumored megamerger with Bristol-Myers Squibb. Despite CEO Pascal Soriot's reputation for fostering growth through internal R&D and smaller, targeted acquisitions, the company's shares are down over 10% for the year and …

Surrozen (NASDAQ: SRZN) swings to $50.2M profit on Boehringer milestone revenue

Citizens Community Bancorp (NASDAQ: CZWI) earnings fall as credit losses rise

Azenta (AZTA) Is Up 6.7% After Raising 2026 Guidance And Completing $50M Buyback – What’s Changed

Zenas Biopharma Inc (ZBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Citizens Inc (NYSE: CIA) posts small Q2 loss but YTD profit

Azenta (AZTA) Stock Rallies on Revenue Strength as Cash Burn Lingers

Segall Bryant & Hamill LLC Buys Shares of 67,058 Citizens & Northern Corp $CZNC

Segall Bryant & Hamill LLC has acquired 67,058 shares of Citizens & Northern Corp (NASDAQ:CZNC) during the first quarter, valued at approximately $1.5 million, representing a 0.37% stake in the company. Institutional investors collectively own 30.83% of the stock. Citizens & Northern recently reported …

Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Growth Surges 9% Amid Strategic ...

Clinic earns grant for AI initiatives

The Cherry Hill Free Clinic has been recognized as a 2026 Champion in Action by Citizens Financial Group, Inc. for its initiatives in building AI readiness. This recognition includes a $50,000 grant, volunteer support, and promotional assistance, which will be used to implement Clinic …

BlackRock, Inc. Expands Stake in Zentalis Pharmaceuticals (ZNTL) with Strategic Share Addition

BlackRock, Inc. has increased its stake in Zentalis Pharmaceuticals (ZNTL) by purchasing 2,441,077 additional shares, bringing its total ownership to 5.20% of the company's outstanding shares. This strategic move, executed at $4.85 per share, reflects BlackRock's confidence in the clinical-stage biopharmaceutical company's long-term prospects, …

Zensar Technologies Q1 Results: Earnings call transcript released

Citizens Bank to distribute Shakespeare in the Park tickets at Woodside branch tomorrow

Citizens Bank will distribute free Shakespeare in the Park tickets at its Woodside branch on Thursday, August 6, making the popular "The Winter's Tale" production more accessible. This event is part of a larger initiative by The Public Theater and Citizens Bank to offer …

Earnings call transcript: Azenta tops Q3 2026 estimates, shares edge higher

Azenta Q3 2026 EPS Tops Expectations, Revenue Up 12%

Azenta, Inc. reported strong Q3 2026 results, with Non-GAAP Diluted EPS of $0.16, significantly exceeding Wall Street's estimate of $0.12. The company's revenue rose 12.0% year-over-year to $161.2M, primarily driven by impressive organic growth of 9.0% and strong performance in its Sample Management Solutions …

AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculation

Astra Zeneca logo on building ©Adobe Stock Images AstraZeneca (NASDAQ:AZN) shares climbed around 6% on Wednesday after Reuters reported that there are "no discussions" between the company and Bristol Myers Squibb (NYSE:BMY) regarding a potential merger, contradicting recent speculation that had unsettled investors. The …

Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

By Maggie Fick and Sabrina Valle Aug 5 (Reuters) - There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a ‌potential deal, a senior source close to the matter told ‌Reuters on Wednesday, quashing the prospect of a mooted mega merger …

Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls

Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top …

AZN spikes 6% after report it denies AstraZeneca-BMS merger talks

Investing.com - AstraZeneca shares surged approximately 6% on Wednesday after a senior source told Reuters there are "no discussions" between AstraZeneca and Bristol Myers Squibb over a potential deal, flatly quashing reports of a merger that would have created a pharmaceutical giant worth nearly …

AstraZeneca climbs Wednesday, outperforms market

Shares of AstraZeneca PLC (AZN) rose 2.52% to £120.36 on Wednesday, outperforming the FTSE 100 Index, which increased by 0.08%. The company's stock closed 23.49% below its 52-week high of £157.32.

AstraZeneca Stock Drops 7% as Merger Talks With Bristol Myers Squibb Surface

AstraZeneca and Bristol Myers Squibb never held merger discussions and are not in talks now, a senior source close to the matter told Reuters on Wednesday. "There is no deal between AstraZeneca and BMS. There never was a deal to be done, and there …

Citizens Financial Group (CFG) Stock Faces Valuation Friction After Strong Q2

Citizens Financial Group (CFG) reported a strong Q2 2026 with significant increases in revenue, net income, and EPS, along with improved net interest margin. Despite these robust results and progress in diversification and efficiency, the stock's valuation faces friction due to its P/E ratio …